| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Internal Medicine,*
University of
Bonn, Bonn, and the Department of Hepatology and
Gastroenterology,
Medizinische Hochschule
Hannover, Hannover, Germany
To define a possible role for changes in the regulation of antigen presentation in fulminant hepatic failure (FHF), we studied the expression of co-stimulatory molecules CD80 (B7-1), CD86 (B7-2), and CD40 along with their ligands CD28 and CD154. We analyzed the liver tissue from patients with FHF (n = 18), chronic liver disease (n = 30), and acute hepatitis (n = 3) and from normal controls (n = 9) by immunohistochemistry and examined the temporal relationship between CD80/CD86 and CD40 expression and disease in the mouse models of galactosamine-lipopolysaccharide and galactosamine-tumor-necrosis-factor-induced FHF. In human controls, faint CD80/CD86 immunoreactivity was restricted to Kupffer cells, and CD40 expression was expressed on bile ducts, macrophages, and sinusoidal endothelial cells (SECs). In FHF, immunoreactivity for CD80 and CD86 was observed on significantly higher numbers of cells, including SECs. Increased CD80/CD86 expression corresponded to increased numbers of CD28-positive lymphocytes. The expression of CD40 was also clearly elevated on virtually all cell types in FHF. In both murine models, CD40 and CD80/CD86 expression was up-regulated before tissue damage could be detected. Our data suggest that up-regulated expression of co-stimulatory molecules might lead to an excessive antigen presentation in FHF as an early step in the pathogenesis before the onset of tissue damage.
This article has been cited by other articles:
 |
|
 |
|
  A. Nolan, M. Weiden, A. Kelly, Y. Hoshino, S. Hoshino, N. Mehta, and J. A. Gold CD40 and CD80/86 Act Synergistically to Regulate Inflammation and Mortality in Polymicrobial Sepsis Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 301 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q Zhou, M Hennenberg, J Trebicka, K Jochem, L Leifeld, E Biecker, T Sauerbruch, and J Heller Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis Gut, September 1, 2006; 55(9): 1296 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Wuensch, R. H. Pierce, and I. N. Crispe Local Intrahepatic CD8+ T Cell Activation by a Non-Self- Antigen Results in Full Functional Differentiation J. Immunol., August 1, 2006; 177(3): 1689 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Leifeld, K. Fink, G. Debska, M. Fielenbach, V. Schmitz, T. Sauerbruch, and U. Spengler Anti-Apoptotic Function of Gelsolin in Fas Antibody-Induced Liver Failure in Vivo Am. J. Pathol., March 1, 2006; 168(3): 778 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A H Lau, A de Creus, L Lu, and A W Thomson Liver tolerance mediated by antigen presenting cells: fact or fiction? Gut, August 1, 2003; 52(8): 1075 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Dory, H. Echchannaoui, M. Letiembre, F. Ferracin, J. Pieters, Y. Adachi, S. Akashi, W. Zimmerli, and R. Landmann Generation and functional characterization of a clonal murine periportal Kupffer cell line from H-2Kb -tsA58 mice J. Leukoc. Biol., July 1, 2003; 74(1): 49 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Petroff, L. Chen, T. A. Phillips, D. Azzola, P. Sedlmayr, and J. S. Hunt B7 Family Molecules Are Favorably Positioned at the Human Maternal-Fetal Interface Biol Reprod, May 1, 2003; 68(5): 1496 - 1504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Schwabe, B. Schnabl, Y. O. Kweon, and D. A. Brenner CD40 Activates NF-{{kappa}}B and c-Jun N-Terminal Kinase and Enhances Chemokine Secretion on Activated Human Hepatic Stellate Cells J. Immunol., June 1, 2001; 166(11): 6812 - 6819. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
